Hudson Valley Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$890K Sell
6,926
-1,199
-15% -$140K 0.11% 101
2026
Q1
$977K Sell
8,125
-150
-2% -$17.3K 0.13% 98
2025
Q4
$871K Sell
8,275
-2,609
-24% -$245K 0.1% 104
2025
Q3
$913K Sell
10,884
-311
-3% -$25.6K 0.1% 106
2025
Q2
$886K Sell
11,195
-2,107
-16% -$167K 0.1% 107
2025
Q1
$1.19M Sell
13,302
-1,979
-13% -$185K 0.14% 88
2024
Q4
$1.52M Sell
15,281
-537
-3% -$55.4K 0.17% 86
2024
Q3
$1.8M Sell
15,818
-2,605
-14% -$309K 0.2% 85
2024
Q2
$2.16M Buy
18,423
+1,525
+9% +$196K 0.28% 79
2024
Q1
$2.23M Sell
16,898
-1,525
-8% -$188K 0.27% 77
2023
Q4
$2.16M Sell
18,423
-2,220
-11% -$230K 0.3% 79
2023
Q3
$2.13M Sell
20,643
-1,881
-8% -$203K 0.3% 80
2023
Q2
$2.6M Sell
22,524
-1,983
-8% -$225K 0.35% 76
2023
Q1
$2.61M Sell
24,507
-1,277
-5% -$138K 0.36% 79
2022
Q4
$2.86M Sell
25,784
-1,885
-7% -$193K 0.43% 69
2022
Q3
$2.38M Sell
27,669
-2,529
-8% -$226K 0.38% 72
2022
Q2
$2.75M Sell
30,198
-4,545
-13% -$403K 0.43% 67
2022
Q1
$2.85M Sell
34,743
-1,714
-5% -$135K 0.38% 71
2021
Q4
$2.79M Sell
36,457
-961
-3% -$76.5K 0.44% 59
2021
Q3
$2.81M Sell
37,418
-3,598
-9% -$274K 0.48% 56
2021
Q2
$3.19M Sell
41,016
-8,409
-17% -$625K 0.55% 50
2021
Q1
$3.64M Sell
49,425
-3,696
-7% -$273K 0.65% 49
2020
Q4
$4.15M Sell
53,121
-133
-0.2% -$10.2K 0.79% 40
2020
Q3
$4.21M Buy
53,254
+521
+1% +$40.8K 0.91% 37
2020
Q2
$3.89M Buy
52,733
+555
+1% +$41.8K 0.9% 38
2020
Q1
$3.83M Buy
52,178
+3,233
+7% +$254K 1.06% 34
2019
Q4
$4.25M Buy
48,945
+2,475
+5% +$203K 0.91% 42
2019
Q3
$3.73M Buy
46,470
+1,745
+4% +$140K 0.86% 43
2019
Q2
$3.58M Sell
44,725
-255
-0.6% -$19.5K 0.83% 45
2019
Q1
$3.57M Sell
44,980
-6,123
-12% -$458K 0.87% 43
2018
Q4
$3.73M Buy
51,103
+9,271
+22% +$654K 0.86% 37
2018
Q3
$2.83M Buy
41,832
+121
+0.3% +$7.71K 0.66% 46
2018
Q2
$2.42M Buy
41,711
+1,325
+3% +$74.8K 0.59% 52
2018
Q1
$2.1M Sell
40,386
-1,640
-4% -$88.6K 0.53% 55
2017
Q4
$2.26M Sell
42,026
-25,939
-38% -$1.44M 0.56% 58
2017
Q3
$4.15M Sell
67,965
-1,881
-3% -$114K 1.08% 31
2017
Q2
$4.27M Sell
69,846
-256
-0.4% -$15.6K 1.18% 26
2017
Q1
$4.25M Buy
70,102
+1,567
+2% +$95.1K 1.19% 25
2016
Q4
$3.85M Buy
68,535
+4,135
+6% +$242K 1.13% 25
2016
Q3
$3.83M Buy
64,400
+828
+1% +$48.4K 1.19% 26
2016
Q2
$3.5M Sell
63,572
-3,681
-5% -$196K 1.12% 30
2016
Q1
$3.4M Buy
67,253
+720
+1% +$35.3K 1.1% 29
2015
Q4
$3.35M Buy
66,533
+551
+0.8% +$27.8K 1.05% 31
2015
Q3
$3.11M Buy
65,982
+1,839
+3% +$97.7K 1.01% 32
2015
Q2
$3.48M Buy
64,143
+211
+0.3% +$11.8K 1.09% 33
2015
Q1
$3.51M Buy
63,932
+220
+0.3% +$12.5K 1.19% 31
2014
Q4
$3.45M Buy
63,712
+897
+1% +$50K 1.41% 28
2014
Q3
$3.55M Buy
62,815
+691
+1% +$38.8K 1.51% 22
2014
Q2
$3.43M Sell
62,124
-5,590
-8% -$305K 1.5% 23
2014
Q1
$3.67M Buy
67,714
+744
+1% +$38.5K 1.57% 24
2013
Q4
$3.2M Buy
66,970
+2,167
+3% +$99.1K 1.41% 27
2013
Q3
$2.94M Sell
64,803
-2,640
-4% -$121K 1.43% 28
2013
Q2
$2.99M Buy
+67,443
New +$3.01M 1.43% 29

Other funds holding MRK

Hudson Valley Investment Advisors's MRK Position: Q2 2026 in Review

Hudson Valley Investment Advisors reduced its Merck (MRK) stake by 15% in Q2 2026, selling an estimated $140K and leaving 6,926 shares worth $890K. The position accounts for 0.11% of the portfolio, ranked #101.

Hudson Valley Investment Advisors first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.27M in Q2 2017. 1,865 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hudson Valley Investment Advisors held 6,926 shares of Merck worth $890K as of Q2 2026.
  • Hudson Valley Investment Advisors sold 1,199 Merck shares in Q2 2026, an estimated $140K.
  • Merck made up 0.11% of Hudson Valley Investment Advisors's portfolio in Q2 2026, its #101 holding.
  • Hudson Valley Investment Advisors first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Hudson Valley Investment Advisors's Merck position peaked at $4.27M in Q2 2017.
  • 1,865 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hudson Valley Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.